Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; Victorian Neurotrauma Initiative; Life Time Care and Support Authority (NSW); University of Western Australia
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003 MDI; Drug: PT005 MDI; Drug: Placebo MDI; Drug: Tiotropium bromide 18 μg (Spiriva Handihaler®); Drug: Formoterol Fumarate 12 μg (Foradil® Aerolizer®); Drug: PT001 MDI
Sponsor: Pearl Therapeutics, Inc.
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin; Drug: placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Intubation, Gastrointestinal
Interventions: Drug: Lignocaine; Drug: Placebo
Sponsor: Queensland Children's Medical Research Institute
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Endometrial Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Greenslopes Private Hospital; University of Queensland; Sullivan and Nicolaides Pathology
Recruiting - verified February 2010